Effect of the aryl substituent on antitumor activity of 2-substituted-1,4-dihydroxy-9,10-anthraquinones and 2-substituted-anthracene-1,4,9,10-tetraones

Archives of Pharmacal Research

Volumn 22, Issue 6, 1999, Pages 592-607

  Nam, Nguyen Hai ^a   Jin, Guang Zhu ^b   Tam, Mai Ngoc ^c   Ahn, Byung Zun ^a  

^a Chungnam National University   (South Korea)

^b YANBIAN UNIVERSITY   (China)

^c INSTITUTE OF CHEMISTRY   (Viet Nam)

Author keywords

1,4 dihydroxy 9,10 anthraquinone; Anthracene 1,4,9,10 tetraones; Antitumor activity; Structure activity relationship

Indexed keywords

ANTHRACENE DERIVATIVE; ANTHRAQUINONE DERIVATIVE; ANTINEOPLASTIC AGENT;

ARTICLE; CELL CULTURE; CELL SURVIVAL; COMPARATIVE STUDY; DRUG EFFECT; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANTHRACENES; ANTHRAQUINONES; ANTINEOPLASTIC AGENTS; CELL SURVIVAL; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0033251558     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02975332     Document Type: Article

References (11)

1. Baik, K. U., Jung, S. H. and Ahn, B. Z. Recognition of Phar-macophore of ar-Turmerone for its anticancer Activity. Arch.Pharm.Res.16, 254-256 (1993a).
2. Baik, K. U., Jung, S. H. and Ahn, B. Z Structure-Activity Relationship of ar-Turmerone Analogues. Arch. Pharm. Res. 16, 219 (1993b)
3. Blanz, J., Mewes, K., Ehninger, G., Gebhardt, R., Zeller, K. P., Evidence for oxidative activation of mitoxantrone in humane. Drug. Metab. Dispos., 19, 871-880 (1991).
4. Ehninger, G., Chuler, U., Proksch, B., Zeller, K. P., Blanz, J., Pharmacokinetics and metabolism of mitoxantrone. A review. Clin. Pharmacokinet., 18 365-38- (1990).
5. Jin, G. Z., Kim, Y., Ho, C. J., Sok, D. E., and Ahn, B. Z., 1,4,9,10-Anthraquinone Derivatives: Synthesis and Antitumor Activity, Arch. Pharm. Pharm. Med. Chem., 331, 380-384 (1998a).
6. Jin, G. Z., Song, G. Y., Zheng, S. G., Kim, Y., Sok, D. E., and Ahn, B. Z., 2- (1-Oxyalkyl)-1,4-dioxy-9,10-anthraquinones: Synthesis and Evaluation of antitumor Activity. Arch. Pharm. Res., 21(2), 208-206 (1998b).
7. Mewes, K.., Blanz, J.., Ehninger, G., Gebhardt, R., and Zeller, K. P., Cytochrome p-450-induced Cytotoxicity of Mitoxantrone by Formation of Electrophilic Intermediates. Cancer Res., 2093, 1, 5135-5142 (1993).
8. National Cancer Institute Protocol, U. S. A (1972)
9. Song, G. Y, Zheng, X. G., Kim, Y., You, Y. J., Sok, D. E., and Ahn, B. Z., Naphthazarin derivatives (II): Formation of glutathione conjugate, inhibition of DNA topoisomerase-I and cytotoxicity. Bioorg. Chem. Med. Chem. Letter, 9, 2407-2412 (1999).
10. Song, G. Y., Kim, Y., Zheng, X, G., You, Y. J., Cho, H., Chung, J. H., Sok, D. E. and Ahn, B. Z. Naphthazarin Derivatives (IV). Synthesis, Inhibition of DNA topoisomerase-I and Cytotoxicity of 2- or 6-Acyl-5, 8-dimethoxy-1,4-naphthoquinones. European J. Med. Chem. (1999) in press.
11. Thayer, P. S., Himnelfarb, L. A., Watt, G. L., Cancer Chemotherapy 2, 1-25 (1971).